Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,692.00
Bid: 2,686.00
Ask: 2,688.00
Change: -14.00 (-0.52%)
Spread: 2.00 (0.074%)
Open: 2,708.00
High: 2,708.00
Low: 2,670.00
Prev. Close: 2,706.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

7 Mar 2024 17:20

RNS Number : 0658G
Coca-Cola HBC AG
07 March 2024

FOR IMMEDIATE RELEASE

Coca-Cola HBC AG

Transactions in own shares

Zug, Switzerland - 7 March 2024 - Coca-Cola HBC AG ("Company") announces that it purchased the following number of its ordinary shares of 6.70 CHF each ("ordinary shares") on the London Stock Exchange, BATS Chi-X Europe and Aquis Stock Exchange Limited, through UBS AG London Branch ("UBS") as part of its share purchase programme announced on Monday 20 November 2023:

Date of transaction

07 March 2024

Number of shares repurchased:

67,999

Lowest price paid per share

£24.4600

Highest price paid per share

£24.7900

Volume weighted average price paid per share (GBP):

£24.6245

Broker

UBS

The purchased ordinary shares will be held in treasury until they are either used to meet the needs of the Company's employee incentive schemes or, by affirmative resolution of the Company's shareholders, cancelled.

As at 7 March 2024, the Company's issued share capital consisted of 373,122,796 ordinary shares, of which 3,596,758 ordinary shares are held by Coca-Cola HBC AG (including the purchased shares) and 3,430,135 ordinary shares are held by its subsidiary, Coca-Cola HBC Services MEPE, in treasury. Therefore, the total number of voting rights in the Company is 366,095,903 which may be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Since announcing the share purchase programme on Monday 20 November 2023, the Company has purchased 2,604,008 of its ordinary shares.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) and Regulation (EU) No 596/2014 as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019, the schedule below provides detailed information about the transactions made by UBS on behalf of the Company as part of the share purchase programme.

http://www.rns-pdf.londonstockexchange.com/rns/0658G_1-2024-3-7.pdf

Schedule of purchases - Aggregated transactions

Trading venue

Volume weighted average price

Aggregated volume

London Stock Exchange

2,461.0893

33,859

BATS

2,464.8008

6,952

Chi-X

2,461.9226

18,113

Aquis

2,466.7444

9,075

Enquiries

Coca-Cola HBC Group

Investor and Analysts:

John Dawson?

Head of Investor Relations

Tel: +44 7522 619509

?john.dawson@cchellenic.com

Jemima Benstead

Investor Relations Manager

Tel: +44 7740 535130

jemima.benstead@cchellenic.com

Sarah Hebert-Lilley

Investor Relations Manager

Tel: +36 30 645 8678

Sarah.Hebert-Lilley@cchellenic.com

Individual Shareholders:

Maria Livaniou

Shareowner Services Manager

Tel: +30 697 444 3270

maria.livaniou@cchellenic.com

Media:

Sonia Bastian

Head of Communications

Tel: +41 7946 88054

sonia.bastian@cchellenic.com

Claire Evans

Group Senior Communications Manager - Corporate

Tel:?+44 7597 562 978

claire.evans@cchellenic.com

About Coca-Cola HBC

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of The Coca-Cola Company. We open up moments that refresh us all, by creating value for our stakeholders and supporting the socio-economic development of the communities in which we operate. With a vision to be the leading 24/7 beverage partner, we offer drinks for all occasions around the clock and work together with our customers to serve 740 million consumers across a broad geographic footprint of 29 countries. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, with consumer-leading beverage brands in the sparkling, adult sparkling, juice, water, sport, energy, ready-to-drink tea, coffee, and premium spirits categories. These include Coca-Cola, Coca-Cola Zero Sugar, Fanta, Sprite, Schweppes, Kinley, Costa Coffee, Caffè Vergnano, Valser, FuzeTea, Powerade, Cappy, Monster Energy, Finlandia Vodka, The Macallan, Jack Daniel's and Grey Goose. We foster an open and inclusive work environment amongst our 33,000 employees and believe that building a more positive environmental impact is integral to our future growth. We rank among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG, FTSE4Good and ISS ESG.

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and is listed on the Athens Exchange (ATHEX: EEE). For more information, please visit https://www.coca-colahellenic.com.

Important notice relating to UBS

UBS AG London Branch ("UBS") is authorised and regulated by the Financial Market Supervisory Authority in Switzerland. It is authorised by the PRA and subject to regulation by the FCA and limited regulation by the PRA in the United Kingdom. UBS is acting exclusively for CCH and no one else in connection with the possible offer and the contents of this announcement. In connection with such matters, UBS will not regard any other person as its client, nor will it be responsible to any other person for providing the protections afforded to its clients or for providing advice in relation to the process, contents of this announcement or any other matter referred to herein.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSUBABRSNUORAR
Date   Source Headline
1st May 201510:47 amRNSAnnual Financial Report
1st May 20158:27 amRNSIssue of Equity and Total Voting Rights
30th Apr 20159:51 amRNSBlocklisting Interim Review
20th Apr 20152:26 pmRNSNotice of Results
20th Mar 201510:04 amRNS2014 Integrated Annual Report
2nd Mar 20155:49 pmRNSSupplementary Prospectus
2nd Mar 20154:08 pmRNSSupplementary Prospectus dated March 2, 2015
26th Feb 20152:20 pmRNSDirector/PDMR Shareholding
20th Feb 201510:26 amRNSAthens Exchange trading date from stock options
18th Feb 20157:00 amRNSDELIVERING RESULTS THROUGH OPERATIONAL FOCUS
22nd Jan 20152:00 pmRNSNotice of Results
2nd Jan 20159:09 amRNSIssue of Equity and Total Voting Rights
11th Dec 201411:08 amRNSDirector/PDMR Shareholding
1st Dec 20147:25 amRNSIssue of Equity and Total Voting Rights
11th Nov 20141:32 pmRNSSupplementary Base Prospectus dated November 11, 2
11th Nov 20141:22 pmRNSPublication of supplementary prospectus
6th Nov 20147:00 amRNSSOLID PERFORMANCE DESPITE VOLUME PRESSURE
3rd Nov 20147:03 amRNSIssue of Equity and Total Voting Rights
7th Oct 20141:07 pmRNSNotice of Results
1st Oct 20142:36 pmRNSDirector/PDMR Shareholding
1st Oct 20147:16 amRNSIssue of Equity and Total Voting Rights
18th Sep 20143:49 pmRNSPublication of Base Prospectus
17th Sep 201410:06 amRNSCOCA-COLA HBC NAMED INDUSTRY LEADER IN THE DJSI
11th Sep 20141:58 pmRNSDirector/PDMR Shareholding
2nd Sep 20147:55 amRNSDirector Declaration
20th Aug 201410:30 amRNSResults for the six months ended June 27, 2014
11th Aug 20147:00 amRNS2014 Half Yearly Financial Report
7th Aug 20147:00 amRNSROBUST PERFORMANCE IN DIFFICULT MARKET CONDITIONS
1st Aug 20147:52 amRNSIssue of equity and total voting rights
24th Jul 20143:32 pmRNSAthens Exchange trading date from stock options
14th Jul 20148:51 amRNSNotice of Results
30th Jun 20147:09 amRNSIntention to delist from the NYSE
27th Jun 20142:21 pmRNSDirectorate Change
26th Jun 20149:45 amRNSResult of AGM
12th Jun 201410:07 amRNSDirector/PDMR Shareholding
2nd Jun 201410:23 amRNSIssue of Equity and Total Voting Rights
28th May 20149:20 amRNSNotice of AGM
28th May 20149:00 amRNSBoard of Directors change and dividend dates
23rd May 20142:23 pmRNSDirector/PDMR Shareholding
16th May 20147:00 amRNSFY EXPECTATIONS UNCHANGED DESPITE CHALLENGING QTR
1st May 20148:00 amRNSIssue of Equity and Total Voting Rights
30th Apr 20148:11 amRNSBlocklisting Interim Review
23rd Apr 20141:34 pmRNSNotice of Results
1st Apr 20147:51 amRNSIssue of Equity and Total Voting Rights
31st Mar 20144:03 pmRNSFiling with the U.S.SEC
31st Mar 20142:29 pmRNSAnnual Financial Report
13th Mar 201412:20 pmRNSSupplementary prospectus
13th Mar 201410:17 amRNSSupplementary Prospectus dated 12 March 2014
11th Mar 20141:44 pmRNSDirector/PDMR Shareholding
14th Feb 20147:00 amRNSResults for the year ended 31 December 2013

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.